Patients, n (%) | LA | CWE | EE |
---|---|---|---|
(n = 251) | (n = 246) | (n = 153) | |
Stable MS (Stage 1) | 37 (14.7) | 47 (19.1) | 22 (14.4) |
Rare exacerbations (≤1 per year, Stage 2a) | 70 (27.9) | 107 (43.5) | 101 (66.0) |
Slow progression (≤0.5 EDSS points per year, Stage 2b) | 48 (19.1) | 35 (14.2) | 6 (3.9) |
Frequent exacerbations (>1 per year, Stage 3a) | 80 (31.9) | 43 (17.5) | 21 (13.7) |
Fast progression (>0.5 EDSS points per year, Stage 3b) | 11 (4.4) | 3 (1.2) | 1 (0.7) |
Not classified/not available | 5 (2.0) | 11 (4.5) | 2 (1.3) |